Lupin Ltd 500257
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₹2,187.45
- Day Range
- ₹2,166.60–2,202.30
- 52-Week Range
- ₹1,106.25–2,312.00
- Bid/Ask
- ₹2,190.10 / ₹2,191.55
- Market Cap
- ₹999.00 Bil
- Volume/Avg
- 12,020 / 54,883
Key Statistics
- Price/Earnings (Normalized)
- 40.85
- Price/Sales
- 4.90
- Dividend Yield (Trailing)
- 0.37%
- Dividend Yield (Forward)
- 0.37%
- Total Yield
- 0.37%
Company Profile
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 19,862
- Website
- https://www.lupin.com
Comparables
Valuation
|
Metric
|
500257
|
532815
|
TORNTPHARM
|
|---|---|---|---|
Price/Earnings (Normalized) | 40.85 | 52.55 | 69.57 |
Price/Book Value | 7.03 | 5.91 | 16.84 |
Price/Sales | 4.90 | 4.08 | 10.67 |
Price/Cash Flow | 30.49 | 36.20 | 46.62 |
Price/Earnings
500257
532815
TORNTPHARM
Financial Strength
|
Metric
|
500257
|
532815
|
TORNTPHARM
|
|---|---|---|---|
Quick Ratio | 0.95 | 0.86 | 0.59 |
Current Ratio | 1.58 | 1.61 | 1.03 |
Interest Coverage | 11.75 | 4.55 | 8.60 |
Quick Ratio
500257
532815
TORNTPHARM
Profitability
|
Metric
|
500257
|
532815
|
TORNTPHARM
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
500257
532815
TORNTPHARM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Xsbfdqbdr | Kcz | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Yqhvqchf | Yltwgn | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Wtdxwhkr | Pwy | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Nsrpflnr | Wwzx | $19.0 Bil | |||
| Viatris Inc
VTRS
| Gggnzywmk | Kmn | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Tsqtmkcr | Rkdm | $13.4 Bil | |||
| Catalent Inc
CTLT
| Vrdtpvnp | Sspvczr | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Lmxbfcvdn | Wxcnl | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Rfnfwlfl | Krzcn | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Nqjgygbpjj | Mmg | $2.5 Bil |
United States